Evidence map›Paper›PMID 33802807›Full record

ArticleMolecules (Basel, Switzerland)2021

Crocetin Mitigates Irradiation Injury in an In Vitro Model of the Pubertal Testis: Focus on Biological Effects and Molecular Mechanisms.

Giulia Rossi, Martina Placidi, Chiara Castellini, Francesco Rea, Settimio D'Andrea, Gonzalo Luis Alonso, Giovanni Luca Gravina, Carla Tatone, Giovanna Di Emidio, Anna Maria D'Alessandro

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. The Therapeutic Effects ofHealth science reports · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Molecules (Basel, Switzerland) · 2021
    Article
  7. Protective effects of saffron (Avicenna journal of phytomedicine
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Giulia RossiLab of Reproductive Technologies, Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-8758-3880
Martina PlacidiLab of Reproductive Technologies, Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-4893-932X
Chiara CastelliniAndrology Unit, Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
Francesco ReaLab of Reproductive Technologies, Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0001-8265-7468
Settimio D'AndreaAndrology Unit, Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
Gonzalo Luis AlonsoQuímica Agrícola, E.T.S.I. Agrónomos y Montes, Departamento de Ciencia y Tecnología Agroforestal y Genética, Universidad de Castilla-La Mancha, Avda. de España s/n, 02071 Albacete, Spain.ORCID 0000-0002-9980-5073
Giovanni Luca GravinaLaboratory of Radiobiology, Division of Radiotherapy, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.
Carla TatoneLab of Reproductive Technologies, Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-4978-2571
Giovanna Di EmidioLab of Reproductive Technologies, Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0001-9442-6923
Anna Maria D'AlessandroLab of Nutritional Biochemistry, Department of Life, Health and Environmental Sciences, University of L'Aquila, 67100 L'Aquila, Italy.ORCID 0000-0002-2212-2207
University of L'Aquila · ITUniversity of Castilla-La Mancha · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infertility is a potential side effect of radiotherapy and significantly affects the quality of life for adolescent cancer survivors. Very few studies have addressed in pubertal models the mechanistic events that could be targeted to provide protection from gonadotoxicity and data on potential radioprotective treatments in this peculiar period of life are elusive. In this study, we utilized an in vitro model of the mouse pubertal testis to investigate the efficacy of crocetin to counteract ionizing radiation (IR)-induced injury and potential underlying mechanisms. Present experiments provide evidence that exposure of testis fragments from pubertal mice to 2 Gy X-rays induced extensive structural and cellular damage associated with overexpression of PARP1, PCNA, SOD2 and HuR and decreased levels of SIRT1 and catalase. A twenty-four hr exposure to 50 μM crocetin pre- and post-IR significantly reduced testis injury and modulated the response to DNA damage and oxidative stress. Nevertheless, crocetin treatment did not counteract the radiation-induced changes in the expression of SIRT1, p62 and LC3II. These results increase the knowledge of mechanisms underlying radiation damage in pubertal testis and establish the use of crocetin as a fertoprotective agent against IR deleterious effects in pubertal period.

Indexed as

AnimalsAutophagyCarotenoidsCatalaseCells, CulturedDown-RegulationELAV-Like Protein 1FertilityGene Expression Regulation, DevelopmentalImmunohistochemistryIn Vitro TechniquesMaleMiceMicrotubule-Associated ProteinsOxidative StressPoly (ADP-Ribose) Polymerase-1CarotenoidsCatalaseElavl1 protein, mouseELAV-Like Protein 1Map1lc3b protein, mouseMicrotubule-Associated ProteinsParp1 protein, mousePoly (ADP-Ribose) Polymerase-1Proliferating Cell Nuclear AntigenSirt1 protein, mouseSirtuin 1Superoxide DismutaseSuperoxide Dismutase 2trans-sodium crocetinateVitamin Aautophagycrocetinfertility preservationHuRoxidative stresspubertal testisradiotherapysaffronSIRT1X-rays

Identifiers

PMID33802807
PMCPMC8002482
OpenAlexW3139187581

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.